20.291.17% ( -0.24 )
Delay Trading: Nov 16, 09:47:48Valuation
Current ValuationThe current P/E ratio is -83.37, within the reasonable range, cheaper than 57.87% of the time in the past 3 years, and the industry ranks 9/9, the industry Median 20.01.
-83.37xP/E
¥20.53Stock price
¥-0.25Earnings per share
-83.37xP/E
Stock price¥20.53Earnings per share¥-0.25
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 39.82x
- Typical range
- -481.75x–110.21x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 20.01x
06121824
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 20.01x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
605266SHJZJ | -9.60x | -- | ¥2.03B |
300937SZHezong Medicine Easy-To-Buy Pharmaceutical | -83.37x | -- | ¥1.96B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
